CA1337345C - Process for the preparation of a thiazepine compound - Google Patents

Process for the preparation of a thiazepine compound

Info

Publication number
CA1337345C
CA1337345C CA000559825A CA559825A CA1337345C CA 1337345 C CA1337345 C CA 1337345C CA 000559825 A CA000559825 A CA 000559825A CA 559825 A CA559825 A CA 559825A CA 1337345 C CA1337345 C CA 1337345C
Authority
CA
Canada
Prior art keywords
compound
reaction
formula
effected
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000559825A
Other languages
English (en)
French (fr)
Inventor
Alan Charles Barker
Robert Jeffrey Copeland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca UK Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of CA1337345C publication Critical patent/CA1337345C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16[b, f]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA000559825A 1987-03-10 1988-02-25 Process for the preparation of a thiazepine compound Expired - Lifetime CA1337345C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8705574 1987-03-10
GB878705574A GB8705574D0 (en) 1987-03-10 1987-03-10 Preparation of thiazepine compound

Publications (1)

Publication Number Publication Date
CA1337345C true CA1337345C (en) 1995-10-17

Family

ID=10613643

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000559825A Expired - Lifetime CA1337345C (en) 1987-03-10 1988-02-25 Process for the preparation of a thiazepine compound

Country Status (25)

Country Link
EP (1) EP0282236B1 (fi)
JP (1) JPH0688991B2 (fi)
KR (1) KR960007088B1 (fi)
AR (1) AR245707A1 (fi)
AT (1) ATE70271T1 (fi)
AU (1) AU595099B2 (fi)
CA (1) CA1337345C (fi)
DD (1) DD271703A5 (fi)
DE (1) DE3866735D1 (fi)
DK (1) DK175310B1 (fi)
ES (1) ES2037822T3 (fi)
FI (1) FI87778C (fi)
GB (2) GB8705574D0 (fi)
GR (1) GR3003324T3 (fi)
HU (1) HU202231B (fi)
IE (1) IE61122B1 (fi)
IL (1) IL85564A (fi)
MW (1) MW388A1 (fi)
MY (1) MY103221A (fi)
NO (1) NO174421C (fi)
NZ (1) NZ223813A (fi)
PH (1) PH25529A (fi)
PT (1) PT86934B (fi)
ZA (1) ZA881350B (fi)
ZW (1) ZW2188A1 (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100867A (en) * 1987-12-15 1992-03-31 Siemens Aktiengesellschaft Process for manufacturing wire or strip from high temperature superconductors and the sheaths used for implementing the process
GB9109557D0 (en) * 1991-05-02 1991-06-26 Wellcome Found Chemical compounds
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
GB9716161D0 (en) * 1997-08-01 1997-10-08 Zeneca Ltd Process
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
IL164155A0 (en) * 2002-03-20 2005-12-18 Teva Pharma Crystalline forms of quetiapine hemifumarate
KR100707050B1 (ko) 2002-11-28 2007-04-13 에스케이 주식회사 10H-디벤조[b,f][1,4]티아제핀-11-온의 제조방법
EP1495008A1 (en) * 2003-02-22 2005-01-12 Teva Pharmaceutical Industries Limited Synthesis of quetiapine and pharmaceutically acceptable salts thereof
US7053115B2 (en) 2003-04-07 2006-05-30 Hetero Drugs Limited Crystalline form of dorzolamide hydrochloride
ES2223294B2 (es) 2003-08-08 2005-10-01 Vita Cientifica, S.L. Procedimiento de preparacion de un compuesto farmaceuticamente activo.
CA2538866A1 (en) * 2003-09-23 2005-03-31 Fermion Oy Preparation of quetiapine
PL368245A1 (en) * 2004-05-28 2005-12-12 CELON PHARMA Sp.z o.o. Method for manufacture of quetiapine
KR101038389B1 (ko) * 2004-06-23 2011-06-01 에스케이바이오팜 주식회사 11-(4-[2-(2-히드록시에톡시)에틸]-1-피페라지닐)-디벤조[b,f][1,4]티아제핀의 제조방법
GB0425729D0 (en) * 2004-11-23 2004-12-22 Pliva Res & Dev Ltd Heterocyclic compounds
WO2006056772A2 (en) * 2004-11-23 2006-06-01 Pliva Hrvatska D.O.O. Salts of quetiapine
EP1841751A1 (en) 2005-01-24 2007-10-10 IPCA Laboratories Limited INDUSTRIAL PREPARATION OF 11-(4-(2-(2-HYDROXYETHOXY ETHYL)-1-PIPERAZINYL)DIBENZO (b,f)-1(1, 4)THIAZEPINE
ES2234447B1 (es) * 2005-03-07 2006-03-01 Union Quimico-Farmaceutica S.A. Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina.
WO2006113425A1 (en) 2005-04-14 2006-10-26 Teva Pharmaceutical Industries Ltd. Process for preparing quetiapine fumarate
WO2006135544A1 (en) * 2005-06-10 2006-12-21 Cambrex Charles City, Inc. SYNTHESIS OF 11-(4[-(2-HYDROXYETHOXY)ETHYL]-PIPERAZINYL)-DIBENZO[b,f][1,4]THIAZEPINE AND ITS FUMARATE SALT
WO2007004234A1 (en) * 2005-07-04 2007-01-11 Usv Limited A PROCESS FOR THE PREPARATION OF 2-[2-(4-DIBENZO[b,f] [L,4] THIAZEPIN-11-yl-1- PIPERAZINYL)ETHOXY] ETHANOL FUMARATE
GB0516603D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Processes for the preparation of organic compounds useful as serotonin receptor antagonists
US8044039B2 (en) 2005-10-28 2011-10-25 Fermion Oy Quetiapine hemifumarate purification by crystallization
PT103884A (pt) 2006-11-17 2008-05-19 Astrazeneca Ab Composições de libertação prolongada e métodos para a sua preparação
US8420807B2 (en) 2008-01-31 2013-04-16 Fermion Oy Process for the preparation of quetiapine
NZ590616A (en) 2008-06-20 2012-09-28 Astrazeneca Ab Dibenzothiazepine derivatives and use thereof
DK2262486T3 (da) 2008-08-01 2013-03-25 Krka Tovarna Zdravil D D Novo Mesto Quetiapin sammensætning
EP2153834A3 (en) 2008-08-07 2010-02-24 Farmaprojects, S.A. Extended release pharmaceutical compositions comprising quetiapine salts
CN101676275B (zh) * 2008-09-17 2014-05-07 北京德众万全药物技术开发有限公司 一种富马酸喹硫平的制备方法
WO2010089259A2 (en) 2009-02-04 2010-08-12 Woerwag R&D Gmbh Sustained release composition containing quetiapine
EP2403841A1 (en) 2009-03-04 2012-01-11 Ranbaxy Laboratories Limited Process for the preparation of quetiapine fumarate
WO2011121602A1 (en) 2010-03-29 2011-10-06 Hikal Limited Process for preparation of dibenzothiazepinone compounds
TR201008261A1 (tr) 2010-10-08 2012-04-24 Sanovel İlaç San. Ve Ti̇c. A.Ş. Kontrollü salım gerçekleştiren ketiapin formülasyonları
EP2848244A1 (en) 2013-09-16 2015-03-18 Yildiz Özsoy Erginer Extended release tablet formulations of quetiapine
CN103524455A (zh) * 2013-10-30 2014-01-22 苏州敬业医药化工有限公司 一种制备2-氯-二苯并[b,f][1,4]硫氮杂卓-11-[10H]酮的方法
CN104447615A (zh) * 2014-02-28 2015-03-25 广东东阳光药业有限公司 喹硫平中间体的制备方法
CN104016945B (zh) * 2014-05-27 2016-06-29 渭南畅通药化科技有限公司 一种半富马酸喹硫平的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792426A (fr) * 1971-12-09 1973-06-07 Wander Ag Dr A Nouveaux derives de la dibenzo(b,f)(1,4)thiazepine, leur preparation etleur application comme medicaments
JPS60155171A (ja) * 1983-12-10 1985-08-15 Wako Pure Chem Ind Ltd ポリメトキシベンジルピペラジン誘導体
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds

Also Published As

Publication number Publication date
KR960007088B1 (ko) 1996-05-27
FI87778C (fi) 1993-02-25
JPS63243081A (ja) 1988-10-07
FI881087A0 (fi) 1988-03-09
MW388A1 (en) 1988-10-12
IL85564A (en) 1992-05-25
GR3003324T3 (en) 1993-02-17
EP0282236B1 (en) 1991-12-11
DK113088D0 (da) 1988-03-02
AU1237888A (en) 1988-09-08
PT86934B (pt) 1992-05-29
AU595099B2 (en) 1990-03-22
DE3866735D1 (de) 1992-01-23
HU202231B (en) 1991-02-28
ZA881350B (en) 1988-12-28
JPH0688991B2 (ja) 1994-11-09
NO881044D0 (no) 1988-03-09
FI881087A (fi) 1988-09-11
DK175310B1 (da) 2004-08-16
AR245707A1 (es) 1994-02-28
ATE70271T1 (de) 1991-12-15
GB8705574D0 (en) 1987-04-15
HUT50336A (en) 1990-01-29
NO881044L (no) 1988-09-12
IL85564A0 (en) 1988-08-31
IE880507L (en) 1988-09-10
PH25529A (en) 1991-07-24
EP0282236A1 (en) 1988-09-14
NO174421C (no) 1994-05-04
FI87778B (fi) 1992-11-13
NO174421B (no) 1994-01-24
IE61122B1 (en) 1994-10-05
NZ223813A (en) 1990-11-27
ES2037822T3 (es) 1993-07-01
ZW2188A1 (en) 1989-10-04
DD271703A5 (de) 1989-09-13
GB8804063D0 (en) 1988-03-23
PT86934A (pt) 1988-04-01
KR880011151A (ko) 1988-10-26
MY103221A (en) 1993-05-29
DK113088A (da) 1988-09-11

Similar Documents

Publication Publication Date Title
CA1337345C (en) Process for the preparation of a thiazepine compound
US20060063927A1 (en) Processes for preparing quetiapine and salts thereof
EP1252151B1 (en) A process for the preparation of quetiapine and intermediates therefor
EP1781665A2 (en) Olanzapine salts and their conversion to olanzapine free base
WO2007004234A1 (en) A PROCESS FOR THE PREPARATION OF 2-[2-(4-DIBENZO[b,f] [L,4] THIAZEPIN-11-yl-1- PIPERAZINYL)ETHOXY] ETHANOL FUMARATE
KR20080108468A (ko) 디벤조티아제핀 화합물의 제조 방법
RU2233275C2 (ru) Способ получения производных дибензотиазепина
EP1660468B1 (en) Procedure for preparing 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl)-dibenzo[b,f][1,4]thiazepine
EP2245021B1 (en) A process for the preparation of quetiapine
US20120071649A1 (en) Process for the preparation of quetiapine fumarate
KR100241089B1 (ko) 2-메르캅토-4-메틸-1,3-티아졸-5-아세트산의 신규한제조방법
EP0341562A1 (en) Process for preparing(+)-and(-)-beta-[(2-amino-1-naphthalenyl)thio]-alpha-hydroxy-4-methoxy-benzenepropanoic acid
JPS6078973A (ja) 1,5−ベンゾチアゼピン誘導体の製法
JPH11199574A (ja) ジベンゾチアゼピン誘導体の製造方法
WO2008125518A2 (en) Process for the preparation of piperazine benzothiazoles
PL209897B1 (pl) Sposób wytwarzania pochodnej dibenzotiazepiny

Legal Events

Date Code Title Description
MKEX Expiry
MKEX Expiry

Effective date: 20121017